The Claim
Twelve weeks of supervised exercise therapy reduces protein-arginine deiminase type 4 (PAD4) mRNA expression by 29% in individuals who do not respond functionally to exercise therapy, with no significant reduction observed in those who do respond functionally.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
After 12 weeks of supervised exercise, people who do not improve functionally show a 29% decrease in PAD4 mRNA levels, while those who improve functionally show no change in PAD4 mRNA levels.
See the scientific wording
Supervised exercise therapy for 12 weeks reduces protein-arginine deiminase type 4 (PAD4) mRNA expression by 29% in non-responders to exercise, but not in responders, suggesting differential effects on inflammation based on functional response to therapy.
When exercise does not improve walking ability, muscle cells experience prolonged metabolic stress, which triggers a signal that turns down the production of a specific inflammation-related protein. In people whose walking improves with exercise, this stress signal does not occur, so the protein level stays the same.
What the research says
1 studyIn people with poor blood flow in their legs, exercise lowered a specific inflammation marker (PAD4) only in those whose walking didn’t get better — not in those who improved their walking. This suggests the body’s inflammation response to exercise can vary depending on how well it responds physically.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.